 | Up a level |
Tsai, C.; Mueller, A.; Maubach, J.; Warschkow, R.; Nussbaum, D. P.; Schmied, B. M.; Blazer, D.; Gloor, B.; Worni, M. (2020). No Difference in Survival between Neo-Adjuvant Chemotherapy and Neo-Adjuvant Chemoradiation Therapy in Gastric Cardia Cancer Patients: A Contemporary View from the National Cancer Database. Digestive surgery, 37(3), pp. 249-257. Karger 10.1159/000501678
Karamitopoulou, Eva; Gloor, B. (2013). Tumour budding is a strong and independent prognostic factor in pancreatic cancer. Reply to comment. European journal of cancer, 49(10), pp. 2458-2459. Elsevier 10.1016/j.ejca.2013.03.028
Karamitopoulou, E.; Zlobec, I.; Gloor, B.; Lugli, A.; Kölzer, V. (2013). Loss of PTEN expression in tumor microenvironment correlates with aggressive behaviour and detects synergistic roles of tumor and stromal cells in Pancreatic Ductal Adenocarcinoma (PDAC). Virchows Archiv, 463(2), pp. 290-291. Springer
Diamantis-Karamitopoulou, E.; Lugli, A.; Gloor, B.; Perren, A.; Zlobec, I. (2013). Decreased CD8+ lymphocytes/tumor budding ratio is associated with metastasis and venous invasion in pancreatic ductal adenocarcinoma (PDAC). Pathologe, 34(6), p. 601. Springer-Medizin-Verlag
Wenning, A. S.; Mooser, C.; Iten, M.; Gloor, B. (2023). Neue Entwicklungen des Managements bei schwerer akuter Pankreatitis. In: Eckart, Joachim; Weigand, Markus A.; Briegel, Josef (eds.) Intensivmedizin - Kompendium und Repetitorium zur interdisziplinären Weiter- und Fortbildung. Ecomed Medizin
